SCHEMBL7053327

SCHEMBL7053327

C[N+](C)CCS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6151204 0.83 APP (0.46)
Methyl Alcohol SCHEMBL7651538 0.70 PTGS1 (0.53)
SCHEMBL21777928 0.69 PTGS1 (0.60)
SCHEMBL2622 0.69 PTGS1 (0.60)
SCHEMBL7055830 0.69
SCHEMBL8649973 0.69
SCHEMBL1065719 0.67 PTGS1 (0.50)
SCHEMBL2288880 0.66 PTGS1 (0.56)
Water SCHEMBL162527 0.66 PTGS1 (0.56)
SCHEMBL20607658 0.66 PTGS1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5084453-A Antibiotics, bactericides BANYU PHARMACEUTICAL CO., LTD. (JP) 1992-01-28 US claimed
WO-2003028739-A2 COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA OR HYPERGLYCEMIA COMPRISING A POLYMER OR ITS SALT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-04-10 WO disclosed
WO-2002032974-A2 POLYMER AND ITS USE FOR THE TREATMENT AND/OR PREVENTION OF HYPERPHOSPHOREMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-25 WO disclosed